VERVE THERAPEUTICS INC

CUSIP: 92539P101 Class: Common Stock

FEDERATED HERMES, INC.'s Holding History (CIK: 0001056288)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 2,645 Value ($000) $30 Avg Close Range
Q1 2025
Shares 301 Value ($000) $1 Avg Close Range
Q4 2024
Shares 6,960 Value ($000) $39 Avg Close Range
Q3 2024
Shares 7,859 Value ($000) $38 Avg Close Range
Q2 2024
Shares 1,151,550 Value ($000) $5,620 Avg Close Range
Q1 2024
Shares 3,556,577 Value ($000) $47,231 Avg Close Range
Q4 2023
Shares 3,980,372 Value ($000) $55,486 Avg Close Range
Q3 2023
Shares 2,532,369 Value ($000) $33,579 Avg Close Range
Q2 2023
Shares 2,402,640 Value ($000) $45,050 Avg Close Range
Q1 2023
Shares 2,402,640 Value ($000) $34,646 Avg Close Range
Q4 2022
Shares 2,078,289 Value ($000) $40,215 Avg Close Range
Q3 2022
Shares 1,749,737 Value ($000) $60,103 Avg Close Range
Q2 2022
Shares 1,097,837 Value ($000) $16,775 Avg Close Range
Q1 2022
Shares 710,237 Value ($000) $16,208 Avg Close Range
Q4 2021
Shares 370,000 Value ($000) $13,642 Avg Close Range
Q3 2021
Shares 370,000 Value ($000) $17,390 Avg Close Range
Q2 2021
Shares 370,000 Value ($000) $22,293 Avg Close Range